Polymyxin B

A cyclic polypeptide antibiotic.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
Supporting references
0
Contradictory references
5
AI-suggested references
1
Clinical trials

General information

Polymyxin B on PubChem


Marketed as

AEROSPORIN; METAMYXIN; POLOMYXIN B; POLY-RX; POLYFAX; POLYXX

 

Structure image - Polymyxin B

CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)[C@@H](C)O


Supporting references

Link Tested on Impact factor Notes Publication date
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
Spike protein 3CLpro In silico
in silico 4.07

Predicted to bind the SARS-CoV-2 spike protein.

Sep/07/2020

AI-suggested references

Clinical trials

ID Title Status Phase Start date Completion date
NCT04352985 Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19 No longer available Jan/01/1970 Jan/01/1970
  • Alternative id - SDI-PMX-013
  • Interventions - Device: Toraymyxin PMX-20R (PMX Cartridge)
  • Study type - Expanded Access:Intermediate-size Population
  • Study results - No Results Available
  • Locations - University of Connecticut Health Center, Farmington, Connecticut, United States|George Washington University, Washington, District of Columbia, United States|Stony Brook University Hospital, Stony Brook, New York, United States
  • Study designs -
  • Enrollment -
  • Age - 18 Years and older   (Adult, Older Adult)
  • Outcome measures -